INO · NASDAQ · Biotechnology

Inovio Pharmaceuticals (INO)

Develops DNA medicines and CELLECTRA devices, led by INO-3107 for recurrent respiratory papillomatosis.

$1.26
vs last close−0.03 (−2.33%)